CN203328838U - Device for manufacturing atrioventricular valve regurgitation animal model through atriums - Google Patents
Device for manufacturing atrioventricular valve regurgitation animal model through atriums Download PDFInfo
- Publication number
- CN203328838U CN203328838U CN2013203762563U CN201320376256U CN203328838U CN 203328838 U CN203328838 U CN 203328838U CN 2013203762563 U CN2013203762563 U CN 2013203762563U CN 201320376256 U CN201320376256 U CN 201320376256U CN 203328838 U CN203328838 U CN 203328838U
- Authority
- CN
- China
- Prior art keywords
- model
- hollow metal
- pipe
- communicating pipe
- cutting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000002837 heart atrium Anatomy 0.000 title claims abstract description 11
- 206010067171 Regurgitation Diseases 0.000 title abstract description 20
- 238000010171 animal model Methods 0.000 title abstract description 11
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000002184 metal Substances 0.000 claims abstract description 34
- 238000005520 cutting process Methods 0.000 claims abstract description 24
- 238000007789 sealing Methods 0.000 claims description 27
- 238000013459 approach Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims 5
- 238000004891 communication Methods 0.000 abstract description 14
- 208000031873 Animal Disease Models Diseases 0.000 abstract description 5
- 238000011558 animal model by disease Methods 0.000 abstract description 5
- 230000005855 radiation Effects 0.000 abstract description 4
- 238000010992 reflux Methods 0.000 abstract description 4
- 238000000465 moulding Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 18
- 206010027727 Mitral valve incompetence Diseases 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 208000014674 injury Diseases 0.000 description 4
- 210000005246 left atrium Anatomy 0.000 description 4
- 210000004115 mitral valve Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000005248 left atrial appendage Anatomy 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 208000005907 mitral valve insufficiency Diseases 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 206010001029 Acute pulmonary oedema Diseases 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010024119 Left ventricular failure Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
Abstract
本实用新型提供一种经心房途径房室瓣膜反流动物模型制作装置,包括用于切开瓣膜的切割杆(1)和带密封连通管的外套管(2),其中:所述带密封连通管的外套管(2)包括连通管(7)和中空金属管(8);所述连通管(7)和中空金属管(8)密封连通;所述切割杆(1)配套安装在中空金属杆(8)中;本实用新型操作简单方便,易于使用,成本低,反流量易控,成模率高,无X线辐射危险,是一种可精确定位瓣叶,运用范围广的专用瓣膜反流动物疾病模型制作装置。
The utility model provides a device for making an animal model of atrioventricular valve regurgitation through the atrium, which includes a cutting rod (1) for cutting the valve and an outer sleeve (2) with a sealed communication tube, wherein: the belt is connected with a sealed tube The outer casing (2) of the pipe includes a connecting pipe (7) and a hollow metal pipe (8); the connecting pipe (7) and the hollow metal pipe (8) are sealed and communicated; the cutting rod (1) is installed on the hollow metal pipe In the rod (8); the utility model is simple and convenient to operate, easy to use, low in cost, easy to control the reverse flow rate, high in molding rate, and free of X-ray radiation risk. A device for making reflux animal disease models.
Description
技术领域 technical field
本实用新型涉及动物疾病模型制作的装置,尤其是一种用于大动物房室瓣膜反流疾病模型的制作装置。 The utility model relates to a device for making animal disease models, in particular to a device for making large animal atrioventricular valve regurgitation disease models. the
背景技术 Background technique
瓣膜反流是一种临床常见的心脏疾患,其中以二尖瓣反流(mitral regurgitation,MR)在临床上最为常见,据报道,超声检查轻度MR在正常人群可高达19%,中度MR或重度MR分别为1.9%和0.2%。二尖瓣反流使得左心房和左心室舒张期负荷加重,可引起肺静脉和肺毛细血管压力升高,继而造成血管扩张和淤血;同时左心室舒张期容量负荷增加,左心室扩大,如果是急性严重的二尖瓣反流,可使左心房和肺静脉压力急剧上升,引发急性肺水肿。慢性MR危害亦大,不及时诊疗将易发生房颤,也常导致肺淤血和体循环灌注低下等左心衰竭,晚期可出现肺动脉高压和全心衰竭,直接威胁生命。正因为此,MR的临床重要性受到越来越多的重视,关于MR的发生机制、病理生理特点以及诊疗新技术的研究广泛开展,一些新的影像诊断技术,尤其是房颤的发生发展变化机制,心衰的内外科治疗手段评价等领域内研究热点均需要一个良好稳定的MR大动物模型。 Valvular regurgitation is a common clinical heart disease, among which mitral regurgitation (MR) is the most common in clinical practice, according to reports, ultrasonography mild MR can be as high as 19% in normal people, moderate MR Or severe MR was 1.9% and 0.2%, respectively. Mitral valve regurgitation increases the diastolic load of the left atrium and left ventricle, which can cause increased pulmonary venous and pulmonary capillary pressure, which in turn causes vasodilation and congestion; at the same time, the left ventricular diastolic volume load increases and the left ventricle expands. Severe mitral regurgitation can cause a sharp rise in the pressure of the left atrium and pulmonary veins, causing acute pulmonary edema. Chronic MR is also harmful. If it is not diagnosed and treated in time, atrial fibrillation will easily occur, and it often leads to left heart failure such as pulmonary congestion and hypoperfusion of the systemic circulation. In the late stage, pulmonary hypertension and whole heart failure may occur, which directly threaten life. Because of this, the clinical importance of MR has been paid more and more attention. Research on the mechanism, pathophysiological characteristics and new technologies of diagnosis and treatment of MR has been carried out extensively. Some new imaging diagnostic techniques, especially the development and changes of atrial fibrillation Research hotspots in fields such as the mechanism of heart failure, the evaluation of medical and surgical treatment methods for heart failure all require a good and stable large animal model of MR. the
目前建立这类动物模型主要通过破坏、改变或影响瓣叶、腱索、乳头肌、瓣环、左心房或左心室等二尖瓣装置的主要结构来达到影响瓣膜紧密闭合,从而造成血液从心室反流到心房,达到制作房室瓣膜反流大动物模型的目的。其中通过损伤瓣叶和腱索最易实现。通过这种方法制作动物瓣膜反流模型有两个途径:开胸和不开胸。传统的开胸的制作二尖瓣反流模型的方法一般需借助体外循环在直视下经左心耳手术切断破坏瓣膜或腱索,这类方法制作的模型较为均一,确切,但费用比较高,创伤比较大;也有见一种不停跳下经心尖部位将二尖瓣损伤的制模方法,这种方法同样技术难度大,创伤仍然比较大。不开胸的方法主指借助导管介入技术在X光的指导下,通过特制的抓钳破坏瓣膜或者 腱索,这种方法一般需要借助超声判断反流大小,由于需要特殊的抓钳在X光下操作,技术要求比较高,难度大,成本高,长距离操作模型的可控性也比较差,往往要么拉伤太重,死亡率很高,要么拉伤较轻,模型不够均一,操作较为烦琐、模型可重复差、常需反复注射造影剂,耗材昂贵,模型制作人员需暴露在X线下,使得这种方法的实际应用受到一定限制,二尖瓣反流模型的建立一度陷入到瓶颈阶段。 At present, the establishment of such animal models mainly affects the tight closure of the valve by destroying, changing or affecting the main structures of the mitral valve device such as valve leaflets, chordae, papillary muscles, valve ring, left atrium or left ventricle, thereby causing blood flow from the ventricle. Regurgitation to the atrium to achieve the purpose of making a large animal model of atrioventricular valve regurgitation. Among them, it is most easily achieved by injuring the valve leaflets and chordae. There are two ways to make animal valvular regurgitation models by this method: opening the chest and not opening the chest. The traditional thoracotomy method of making mitral valve regurgitation models generally needs to use extracorporeal circulation to cut off the damaged valve or chordae through the left atrial appendage under direct vision. The models made by this method are relatively uniform and accurate, but the cost is relatively high. The trauma is relatively large; there is also a model-making method in which the mitral valve is damaged by jumping off the apex of the heart continuously. This method is also technically difficult and the trauma is still relatively large. The non-thoracotomy method mainly refers to the use of catheter intervention technology under the guidance of X-rays to destroy the valve or chordae with special graspers. This method generally requires the use of ultrasound to determine the size of the regurgitation. The lower operation requires relatively high technical requirements, great difficulty, and high cost. The controllability of the long-distance operation model is also relatively poor. Often, the strain is too severe and the mortality rate is high, or the strain is light, the model is not uniform enough, and the operation is relatively difficult. It is cumbersome, the model is poorly reproducible, repeated injections of contrast agents are often required, the consumables are expensive, and the model makers need to be exposed to X-rays, which limits the practical application of this method, and the establishment of mitral regurgitation models was once stuck in a bottleneck stage. the
由上所述,现有的房室瓣膜反流动物疾病模型制模技术存在如下不足:传统外科手术创伤较大,动物易感染,动物死亡率高,费用高昂;介入X线下不开胸的方法需特制的制模工具,操作烦琐、技术难度大、不易掌握反流量大小、模型制作可重复性差、死亡率高,模型均一性差,常需反复注射造影剂,耗材昂贵,模型制作人员及动物均需暴露在大剂量X线照射,使得其使用范围有限。 From the above, the existing atrioventricular valve regurgitation animal disease modeling technology has the following deficiencies: the trauma of traditional surgical operations is large, the animals are susceptible to infection, the mortality rate of animals is high, and the cost is high; The method requires special modeling tools, cumbersome operation, high technical difficulty, difficult to grasp the size of reflux flow, poor reproducibility of model making, high mortality rate, poor model uniformity, frequent injection of contrast agent, expensive consumables, difficult for model makers and animals All need to be exposed to high-dose X-ray radiation, which makes its use limited. the
实用新型内容 Utility model content
为了克服上述技术问题,本实用新型的目的是针对目前房室瓣膜反流动物疾病模型的迫切需要,传统疾病模型外科制备方法的创伤大,易发感染,动物死亡率高,费用高昂的缺点,提供一种经心房途径房室瓣膜反流动物模型制作装置。 In order to overcome the above-mentioned technical problems, the purpose of this utility model is aimed at the urgent need of the atrioventricular valve regurgitation animal disease model at present, the trauma of the traditional disease model surgical preparation method is large, prone to infection, the animal mortality rate is high, and the shortcomings of high cost, Provided is a device for making an animal model of atrioventricular valve regurgitation via atrial route. the
为了实现上述目的,本实用新型所述的一种经心房途径房室瓣膜反流动物模型制作装置,包括用于切开瓣膜的切割杆和带密封连通管的外套管,其中: In order to achieve the above object, a device for making an animal model of atrioventricular valve regurgitation through the atrium described in the utility model includes a cutting rod for cutting the valve and an outer sleeve with a sealed connecting tube, wherein:
所述带密封连通管的外套管包括连通管和中空金属管; The outer casing with a sealed connecting pipe includes a connecting pipe and a hollow metal pipe;
所述连通管和中空金属管密封连通; The connecting pipe is in sealed communication with the hollow metal pipe;
所述切割杆配套安装在中空金属管中。 The cutting rod is matched and installed in the hollow metal tube. the
所述切割杆包括金属杆和金属杆底端连接的切割倒钩。 The cutting rod includes a metal rod and a cutting barb connected to the bottom end of the metal rod. the
所述切割杆还包括手持套件,手持套件固定连接于金属杆的另一端。 The cutting rod also includes a hand-held kit, which is fixedly connected to the other end of the metal rod. the
所述带密封连通管的外套管还包括密封头部;其中: The outer casing with the sealing connecting pipe also includes a sealing head; wherein:
所述密封头部设有密封圆孔和侧密封连接孔; The sealing head is provided with a sealing round hole and a side sealing connection hole;
所述中空金属管与密封圆孔密封连接; The hollow metal tube is sealed and connected with the sealing round hole;
所述连通管与侧密封连接孔密封连接。 The communication pipe is sealingly connected with the side seal connecting hole. the
所述带密封连通管的外套管还包括阀门,阀门与连通管的另一端密封连接。 The outer casing with a sealed communication pipe also includes a valve, which is sealed and connected with the other end of the communication pipe. the
本实用新型所述的经心房途径房室瓣膜反流动物模型制作装置的优点是: The advantage of the atrioventricular valve regurgitation animal model making device through the atrium approach described in the utility model is:
1.使用小切口经心房房室瓣膜反流动物模型制作装置制作动物房室瓣膜反流模型操作简单,易于使用,可实现微创小切口,心脏无需停跳,无需体外循环、反流量可半定量控制,可精确定位到拟破坏的瓣叶,成模率高。 1. Using a small incision transatrial ventricular valve regurgitation animal model making device to make animal atrioventricular valve regurgitation models is simple to operate, easy to use, and can achieve minimally invasive small incisions, without stopping the heart, without extracorporeal circulation, and semi-quantitative control of the reflux flow , can accurately locate the leaflet to be destroyed, and the modeling rate is high. the
2.使用瓣膜切断装置制作动物瓣膜反流模型无需使用X射线成像,无X线辐射危险、成本低、易于推广,可广泛运用。 2. Using the valve cutting device to make animal valve regurgitation models does not require X-ray imaging, has no risk of X-ray radiation, is low in cost, easy to promote, and can be widely used. the
附图说明 Description of drawings
图1为本实用新型一种实施例主视图。 Fig. 1 is a front view of an embodiment of the utility model. the
图2为本实用新型一种实施例中切割杆主视图。 Fig. 2 is a front view of the cutting rod in an embodiment of the utility model. the
图3为本实用新型一种实施例中带密封连通管的外套管主视图。 Fig. 3 is a front view of an outer casing with a sealed communication pipe in an embodiment of the present invention. the
具体实施方式 Detailed ways
下面参考附图来说明本实用新型的实施例。在本实用新型的一个附图或一种实施方式中描述的元素和特征可以与一个或更多个其他附图或实施方式中示出的元素和特征相结合。应当注意,为了清楚的目的,附图和说明中省略了与本实用新型无关的、本领域普通技术人员已知的部件或处理的表示和描述。 Embodiment of the utility model is described below with reference to accompanying drawing. Elements and features described in one drawing or one embodiment of the present invention may be combined with elements and features shown in one or more other drawings or embodiments. It should be noted that, for the purpose of clarity, representation and description of components or processes that are not relevant to the present invention and known to those of ordinary skill in the art are omitted in the drawings and descriptions. the
下面结合附图对本实用新型做进一步描述。 Below in conjunction with accompanying drawing, the utility model is further described. the
图1为本实用新型一种实施例主视图,如图1中所示,本实用新型所述的一种经心房途径房室瓣膜反流动物模型制作装置,包括用于切开瓣膜的切割杆1和带密封连通管的外套管2,其中:所述带密封连通管的外套管2包括连通管7和中空金属管8;连通管7和中空金属管8密封连通。
Fig. 1 is a front view of an embodiment of the utility model, as shown in Fig. 1, a kind of atrioventricular valve regurgitation animal model making device through the atrium approach described in the utility model, comprises the cutting bar for cutting
图2为本实用新型一种实施例中切割杆主视图,如图2中所示,所述切割杆1包括金属杆4、切割倒钩5、手持套件3构成,金属杆4一端设置有切割倒钩5,手持套件3固定连接于金属杆4的另一端。其中,所述的手持套件3由塑胶材料制成,带有便于捏持或握持的纹路;所述的金属杆4由强度不锈金属制成,直径不大于带密封连通管的外套管2内径,优选为3mm;长度略长于带密封连通管的外套管2,优选20cm;所述切割倒钩5呈“L”钩型利刀状,其横截面不超过金属杆所在横截面。
Fig. 2 is a front view of the cutting rod in an embodiment of the utility model, as shown in Fig. 2, the cutting
图3为本实用新型一种实施例中带密封连通管的外套管主视图,如图3中所示,所述带密封连通管的外套管2包括密封头部6、连通管7、中空金属管8、三通阀门11;其中:所述密封头部6设有密封圆孔9和侧密封连接孔10;中空金属管8与密封圆孔9密封连接;连通管7与侧密封连接孔10密封连接;,三通阀门11与连通管7的另一端密封连接。
Fig. 3 is a front view of an outer casing with a sealing connecting pipe in an embodiment of the present invention. As shown in Fig. 3, the
其中,所述的密封头部6为一矮圆柱形中空塑胶材料制成,所述的密封圆孔9圆心与中空金属管8横截面圆心在同一直线上,密封圆孔9的直径于中空金属管8相同,所述的中空金属管8由强度不锈中空金属制成,直径大于金属杆4,优选内径为3.5mm,优选外径为4mm,长度小于金属杆4,优选直径为15cm;所述的连通管7为塑胶中空软管制成,一端连接于密封头部6,另一端与三通阀门11连接。
Wherein, the sealing
本实用新型所述的经心房途径房室瓣膜反流动物模型制作装置的使用过程是: The use process of the transatrial approach atrioventricular valve regurgitation animal model making device described in the utility model is:
使用前,先将待制模的动物常规麻醉,气管插管,建立静脉通路,如果建立左侧房室瓣膜反流模型,动物右侧卧位,第2-3肋间小切口开胸,切开心包,在左心耳上缝好荷包,将带密封连通管的外套管2经预缝合好的荷包插入左心耳,进入左房,继续深入将穿过二尖瓣膜,此时可通过连通管7流出的血液的速度缓急判断中空金属管8是否进入心室,当中空金属管8进入穿过二尖瓣后,取出切割杆1经密封头部6的密封圆孔9插入,穿过中空金属管8,待切割倒钩5从中空金属管8伸出后,即可试探往回撤,当感觉切割倒钩5挂住瓣膜组织后稍用力往回撤出切割杆1,此时即可切断瓣膜,完成制模操作,其他房室瓣膜反流动物疾病模型可参照二尖瓣反流动物疾病模型制作方法制作模型,借助超声机等设备可以实时观察制模的成功状况。
Before use, the animal to be modeled should be routinely anesthetized, tracheal intubated, and intravenous access established. If the left atrioventricular valve regurgitation model is established, the animal should be placed in the right lateral position. Happy bag, sew a purse on the left atrial appendage, insert the pre-sewn purse through the
本实用新型操作简单方便,易于使用,成本低,反流量易控,成模率高,无X线辐射危险,是一种可精确定位瓣叶,运用范围广的专用瓣膜反流动物疾病模型制作装置。 The utility model is simple and convenient in operation, easy to use, low in cost, easy to control the reflux flow, high in molding rate, and free from X-ray radiation risk. device. the
虽然已经详细说明了本实用新型及其优点,但是应当理解在不超出由所附的权利要求所限定的本实用新型的精神和范围的情况下可以进行各种改变、替 代和变换。而且,本申请的范围不仅限于说明书所描述的过程、设备、手段、方法和步骤的具体实施例。本领域内的普通技术人员从本实用新型的公开内容将容易理解,根据本实用新型可以使用执行与在此所述的相应实施例基本相同的功能或者获得与其基本相同的结果的、现有和将来要被开发的过程、设备、手段、方法或者步骤。因此,所附的权利要求旨在在它们的范围内包括这样的过程、设备、手段、方法或者步骤。 Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present application is not limited to the specific embodiments of the procedures, devices, means, methods and steps described in the specification. Those of ordinary skill in the art will readily understand from the disclosure of the utility model that, according to the utility model, it is possible to use existing and existing products that perform substantially the same functions or obtain substantially the same results as the corresponding embodiments described herein. A process, device, means, method or procedure to be developed in the future. Accordingly, the appended claims are intended to include within their scope such processes, means, means, methods or steps. the
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013203762563U CN203328838U (en) | 2013-06-27 | 2013-06-27 | Device for manufacturing atrioventricular valve regurgitation animal model through atriums |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013203762563U CN203328838U (en) | 2013-06-27 | 2013-06-27 | Device for manufacturing atrioventricular valve regurgitation animal model through atriums |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203328838U true CN203328838U (en) | 2013-12-11 |
Family
ID=49697546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013203762563U Expired - Lifetime CN203328838U (en) | 2013-06-27 | 2013-06-27 | Device for manufacturing atrioventricular valve regurgitation animal model through atriums |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203328838U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300938A (en) * | 2013-06-27 | 2013-09-18 | 中国医学科学院阜外心血管病医院 | Trans-atrial pathway atrioventricular valve regurgitation animal modeling device and method |
| CN108403249A (en) * | 2018-01-24 | 2018-08-17 | 四川省人民医院 | A kind of aortic incompetence animal model making device |
-
2013
- 2013-06-27 CN CN2013203762563U patent/CN203328838U/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300938A (en) * | 2013-06-27 | 2013-09-18 | 中国医学科学院阜外心血管病医院 | Trans-atrial pathway atrioventricular valve regurgitation animal modeling device and method |
| CN103300938B (en) * | 2013-06-27 | 2015-05-20 | 中国医学科学院阜外心血管病医院 | Trans-atrial pathway atrioventricular valve regurgitation animal modeling device |
| CN108403249A (en) * | 2018-01-24 | 2018-08-17 | 四川省人民医院 | A kind of aortic incompetence animal model making device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204133530U (en) | Occluder for left auricle | |
| WO2016049991A1 (en) | Left atrial appendage occlusion apparatus | |
| CN108478258B (en) | intracardiac cutter | |
| CN203328838U (en) | Device for manufacturing atrioventricular valve regurgitation animal model through atriums | |
| CN103300938B (en) | Trans-atrial pathway atrioventricular valve regurgitation animal modeling device | |
| CN203777464U (en) | Percutaneous puncture minimally-invasive cardiac surgery balloon blocking, cardioplegic solution perfusing and exhausting cannula | |
| CN205235048U (en) | Heart exhaust auxiliary device | |
| CN209996542U (en) | A heart valve regurgitation tester | |
| CN203075346U (en) | Infant intra-arterial infusion syringe needle | |
| CN206404175U (en) | A kind of rat self administration jugular vein puts the improvement coupling devices of pipe | |
| CN212281459U (en) | Valve spreader with suction device | |
| CN204600796U (en) | A kind of Simple conveying device for insertion type artificial cardiac valve | |
| CN211357064U (en) | Extracorporeal circulation left heart drainage tube | |
| CN212118199U (en) | A device for interventional therapy of adult congenital heart disease guided by echocardiography | |
| CN108403249B (en) | A device for making an animal model of aortic regurgitation | |
| CN204092789U (en) | For the left heart drainage-tube of department of cardiac surgery cardiopulmonary bypass surgery | |
| CN211633412U (en) | Fascia dilator for percutaneous nephroscope | |
| CN111407332A (en) | Valve spreader with suction device | |
| CN223169835U (en) | Animal ear edge blood vessel puncture fixer | |
| CN119856999A (en) | Miniature coronary artery sacculus plugging device | |
| CN216493029U (en) | Novel frog heart perfusion experiment intubation tube | |
| CN217548170U (en) | Ultrasound-guided cyst puncture sclerotherapy device | |
| CN207253352U (en) | Blood vessel snare pin | |
| CN207136838U (en) | Left room pulmonary artery central vein combines pressure catheter | |
| CN209447401U (en) | Frog heart cannula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20131211 Effective date of abandoning: 20150520 |
|
| AV01 | Patent right actively abandoned |
Granted publication date: 20131211 Effective date of abandoning: 20150520 |
|
| RGAV | Abandon patent right to avoid regrant |